1 study found for:    17675511 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting In Situ Vaccine for Low-Grade Lymphoma: Combination of Intratumoral Flt3L and Poly-ICLC With Low-Dose Radiotherapy
Condition: Low-Grade B-cell Lymphoma
Interventions: Drug: rhuFlt3L/CDX-301;   Drug: Poly-ICLC

Indicates status has not been verified in more than two years